Exactech Unveils Groundbreaking Scapula Solution for Patients
Exactech's Innovative Scapula Reconstruction System Receives FDA Clearance
Exactech, a renowned name in the medical technology field, recently celebrated a milestone with the FDA's clearance of their groundbreaking Equinoxe Scapula Reconstruction System. This approval marks a pivotal moment for orthopedic surgeons treating acromial and scapular spine fractures. The system is designed to address a common yet significant complication that can arise following reverse total shoulder arthroplasty (rTSA).
The Challenge of Acromial and Scapular Fractures
Acromial and scapular fractures, while rare, can lead to serious complications for patients undergoing rTSA procedures. Studies show that the rate of these fractures can average around 2.8 percent, but some specific diagnoses can bump that figure as high as 10.9 percent. The absence of a reliable treatment option for these challenging situations is what propelled Exactech to innovate.
Collaborative Design Efforts
Leading the charge in the design of the Equinoxe Scapula Reconstruction System are orthopedic experts including Dr. Jonathan Levy, Dr. Howard Routman, Dr. Peter Cole, and others with extensive experience in rTSA. Chris Roche, Exactech's Senior Vice President for Extremities, emphasizes the collaborative spirit of the design process, showcasing how bringing together experts can result in significant advancements in surgical technology.
The System's Versatility
This revolutionary system is particularly notable for its versatility, allowing orthopedic surgeons to choose from various techniques for scapular fracture treatment, including single and dual plating. The range of anatomically contoured plates provided in multiple lengths aims to accommodate the diverse anatomy of patients while effectively managing fractures to restore functionality.
A Game-Changer in Surgical Treatment
Dr. Howard Routman, an orthopedic surgeon, expressed enthusiasm about the system's dual plating design, noting how it caters to the complex nature of scapular anatomy and fracture patterns. This innovative solution respects the unique biomechanics involved in rTSA treatments, offering surgeons a dependable method to tackle an area of surgery that has lacked depth in treatment options.
Features for Enhanced Support
The Equinoxe Scapula Reconstruction System distinguishes itself with various plate designs featuring integral hooks to provide support against both the action of the deltoid muscle and the mechanical stress imposed by the rTSA prosthesis. This attention to detail in the design stems from extensive laboratory research indicating that lateral hook plates significantly enhance fixation at the lateral acromion.
Dr. Jonathan Levy highlighted the importance of this development by stating, "This implant system has been designed specifically for acute treatment of fractures, which is essential for managing a frequently devastating complication—in acromial fractures." The intention behind this system is not just to prevent further complications but to promote healing and recovery in affected patients.
Looking Forward
As the Equinoxe Scapula Reconstruction System prepares for a pilot launch within the U.S., the orthopedic community eagerly anticipates its availability. Exactech's dedication to addressing the intricacies of orthopedic surgical solutions is evident through their focus on unmet clinical needs. By introducing this innovative system, Exactech not only aims to enhance surgical options but also aspires to improve patient outcomes significantly.
Exactech stands as a leader in delivering innovative orthopedic solutions, paving the way for improved functionalities in surgical implants and practices. Through the integration of smart technologies and their Active Intelligence® ecosystem, the company's mission remains focused on enriching patient mobility, ultimately changing lives for the better.
Frequently Asked Questions
What is the Equinoxe Scapula Reconstruction System?
The Equinoxe Scapula Reconstruction System is an innovative solution developed by Exactech for treating acromial and scapular spine fractures.
Who were the design experts behind the system?
Notable orthopedic surgeons such as Dr. Jonathan Levy and Dr. Howard Routman led the design efforts, emphasizing their extensive experience in rTSA.
What are the limitations of existing treatment options?
Previously, there was a lack of specialized treatments for acromial and scapular fractures, which this system is designed to address effectively.
How does the system enhance surgical procedures?
Its versatility allows for single or dual plating techniques, effectively managing a range of fracture types and anatomy.
When will the system be available for use?
The Equinoxe Scapula Reconstruction System is set for a pilot launch with limited availability in the U.S. shortly, with wider distribution expected to follow.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
